The Effect of Vitamin D Supplementation on Inflammatory and Hemostatic Markers and Disease Activity in Patients with Systemic Lupus Erythematosus: A Randomized Placebo-controlled Trial

REFERENCES

1. 1.↵
   1. van Elten E,
   2. Mathieu C

   . Immunoregulation by 1.25 dihydroxyvitamin D3: basic concepts. J Steroid Mol Biol 2005;97:93–101.

   OpenUrlCrossRef
2. 2.↵
   1. Hewison M

   . Vitamin D and the immune system: New perspectives on an old theme. Endocrinol Metab Clin North Am 2010;39:365–79.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Deluca HF,
   2. Cantorna MI

   . Vitamin D: Its role and uses in immunology. FASEB J 2001;15:2579–85.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Adorini A,
   2. Penna G

   . Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol 2008;4:404–12.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Kamen DL,
   2. Tangpricha V

   . Vitamin D and molecular actions on the immune system: Modulation of innate and autoimmunity. J Mol Med 2010;88:441–50.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Baeke F,
   2. Takishi T,
   3. Korf H,
   4. Gysemans C,
   5. Mattieu C

   . Vitamin D: modulator of the immune system. Curr Opin Pharmacol 2010;10:482–96.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Cutolo M

   . Vitamin D and autoimmune rheumatic diseases. Rheumatology 2009;48:210–2.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Kamen D,
   2. Aranou C

   . The link between vitamin D deficiency and systemic lupus erythematosus. Curr Rheumatol Rep 2008;10:273–80.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Arnson Y,
   2. Amital H,
   3. Shoenfeld Y

   . Vitamin D and autoimmunity: New aetiological and therapeutic considerations. Ann Rheum Dis 2007;66:1137–42.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Cutolo M,
    2. Otsa K

    . Review: Vitamin D, immunity and lupus. Lupus 2008;17:6–10.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Autier P,
    2. Gandini S

    . Vitamin D supplementation and total mortality: A meta-analysis of randomized controlled trials. Arch Intern Med 2007;167:1730–7.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Abe J,
    2. Nakamura K,
    3. Takita Y,
    4. Xlakano T,
    5. Irie H,
    6. Nishii Y

    . Prevention of immunological disorders in MRL//lpr mice by a new synthetic analogue of vitamin D3 22oxa-1 alpha, 25 dihydroxyvitamin D3. J Nutr Sci Vitaminol 1990;36:21–31.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. Adorini L

    . 1,25 dihydroxyvitamin D3 analogs as potential therapies in transplantation. Curr Opin Invest Drugs 2002;3:1458–63.

    OpenUrlPubMed
14. 14.↵
    1. Tan EM,
    2. Cohen AS,
    3. Fries JF,
    4. Masi AT,
    5. McShane DJ,
    6. Rothfield NF,
    7. et al.

    The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271–7.

    OpenUrlCrossRefPubMed
15. 15.↵
    1. Hochberg MC

    . Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.

    OpenUrlCrossRefPubMed
16. 16.↵
    1. Kamen DL

    . Vitamin D in lupus — New kid on the block? Bull NYU Hosp Jt Dis 2010;68:218–22.

    OpenUrlPubMed
17. 17.↵
    1. Gladman DD,
    2. Ibanez D,
    3. Urowitz MB

    . Systemic Lupus Erythematosus Disease Activity Index 2000. J Rheumatol 2002;29:288–91.

    OpenUrlAbstract/FREE Full Text
18. 18.↵
    1. Holick MF

    . Vitamin D deficiency. N Engl J Med 2007;357:266–81.

    OpenUrlCrossRefPubMed
19. 19.↵
    1. Holick MF

    . High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 2006;81:353–73.

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Ruiz-Irastorza G,
    2. Egurbide MV,
    3. Olivares N,
    4. Martinez-Berriotxoa A,
    5. Aguirre C

    . Vitamin D deficiency in systemic lupus erythematosus: Prevalence, predictors and clinical consequences. Rheumatology 2008;47:920–30.

    OpenUrlCrossRefPubMed
21. 21.↵
    1. Ruiz-Irastorza G,
    2. Gardo S,
    3. Olivares N,
    4. Egurbide MV,
    5. Aguirre C

    . Changes in vitamin D levels in patients with systemic lupus erythematosus: Effects on fatigue, disease activity and damage. Arthritis Care Res 2010;62:1160–5.

    OpenUrlCrossRef
22. 22.↵
    1. Kamen DL,
    2. Cooper GS,
    3. Bouali H,
    4. Shaftman SR,
    5. Hollis BW,
    6. Gilkeson GS

    . Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev 2006;5:114–7.

    OpenUrlCrossRefPubMed
23. 23.↵
    1. Carvalho JF,
    2. Blank M,
    3. Kiss E,
    4. Tarr T,
    5. Amital H,
    6. Shoenfeld Y

    . Anti-vitamin D, vitamin D in SLE: Preliminary results. Ann NY Acad Sci 2007;1109:550–7.

    OpenUrlCrossRefPubMed
24. 24.↵
    1. Amital H,
    2. Szekanecz Z,
    3. Szücs G,
    4. Dankó K,
    5. Nagy E,
    6. Csépány T,
    7. et al.

    Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: Is it time to routinely supplement patients with SLE with vitamin D? Ann Rheum Dis 2010;69:1155–7.

    OpenUrlAbstract/FREE Full Text
25. 25.↵
    1. Wu PW,
    2. Rhew EY,
    3. Dyer AR,
    4. Dunlop DD,
    5. Langman CB,
    6. Price H,
    7. et al.

    25-hydroxyvitamin D and cardiovascular risk factors in women with systemic lupus erythematosus. Arthritis Rheum 2009;61:1387–95.

    OpenUrlCrossRefPubMed
26. 26.↵
    1. Toloza SM,
    2. Cole DE,
    3. Gladman DD,
    4. Ibanez D,
    5. Urowitz MB

    . Vitamin D insufficiency in a large female SLE cohort. Lupus 2010;19:13–9.

    OpenUrlCrossRefPubMed
27. 27.↵
    1. Aringer M,
    2. Smolen JS

    . Tumor necrosis factor and other proinflammatory cytokines in systemic lupus erythematosus: A rationale for therapeutic intervention. Lupus 2004;13:344–7.

    OpenUrlCrossRefPubMed
28. 28.↵
    1. Gabay C,
    2. Cakir N,
    3. Moral F,
    4. Roux-Lombard P,
    5. Meyer O,
    6. Dayer JM,
    7. et al.

    Circulating levels of tumor necrosis factor, soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity. J Rheumatol 1997;24:303–8.

    OpenUrlPubMed
29. 29.↵
    1. Chen S,
    2. Sims GP,
    3. Chen XX,
    4. Gu YY,
    5. Chen S,
    6. Lipsky PE

    . Modulatory effects of 1.25 dihydroxyvitamin D3 on human B cell differentiation. J Immunol 2007;179:1634–47.

    OpenUrlAbstract/FREE Full Text
30. 30.↵
    1. Ben-Zvi I,
    2. Aranow C,
    3. Mackay M,
    4. Stanevsky A,
    5. Kamen DL,
    6. Marinescu LM,
    7. et al.

    The impact of vitamin D on dendritic cell function in patients with systemic lupus erythematosus. PLos One 2010;5:e9193.

    OpenUrlCrossRefPubMed
31. 31.↵
    1. Ritterhouse LL,
    2. Crowe SR,
    3. Niewold TB,
    4. Kamen DL,
    5. Macwana SR,
    6. Roberts VC,
    7. et al.

    Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus. Ann Rheum Dis 2011;70:1569–74.

    OpenUrlAbstract/FREE Full Text